You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

EPHEDRINE SULFATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for ephedrine sulfate and what is the scope of patent protection?

Ephedrine sulfate is the generic ingredient in four branded drugs marketed by Exela Pharma, Endo Operations, Nexus, Amneal, Caplin, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Mankind Pharma, Renew Pharms, Sagent Pharms Inc, Sandoz, Xiromed, and Zydus Pharms, and is included in seventeen NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ephedrine sulfate has eleven patent family members in nine countries.

There are thirteen drug master file entries for ephedrine sulfate. Twenty-one suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for EPHEDRINE SULFATE
International Patents:11
US Patents:7
Tradenames:4
Applicants:16
NDAs:17
Drug Master File Entries: 13
Finished Product Suppliers / Packagers: 21
Raw Ingredient (Bulk) Api Vendors: 21
Clinical Trials: 14
Patent Applications: 891
Drug Prices: Drug price trends for EPHEDRINE SULFATE
What excipients (inactive ingredients) are in EPHEDRINE SULFATE?EPHEDRINE SULFATE excipients list
DailyMed Link:EPHEDRINE SULFATE at DailyMed
Drug Prices for EPHEDRINE SULFATE

See drug prices for EPHEDRINE SULFATE

Recent Clinical Trials for EPHEDRINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Instituto Mexicano del Seguro SocialPhase 4
Fayoum UniversityPhase 1
Ain Shams UniversityN/A

See all EPHEDRINE SULFATE clinical trials

Generic filers with tentative approvals for EPHEDRINE SULFATE
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign Up50MG/ML (50MG/ML)SOLUTION;INTRAVENOUS

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Medical Subject Heading (MeSH) Categories for EPHEDRINE SULFATE
Paragraph IV (Patent) Challenges for EPHEDRINE SULFATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
EPHEDRINE SULFATE Injection ephedrine sulfate 25 mg/5 mL and 50 mg/10 mL 213994 1 2023-03-17
EMERPHED Injection ephedrine sulfate 50 mg/10 mL 213407 1 2021-10-14

US Patents and Regulatory Information for EPHEDRINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Operations EPHEDRINE SULFATE ephedrine sulfate SOLUTION;INTRAVENOUS 213994-002 Apr 22, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations EPHEDRINE SULFATE ephedrine sulfate SOLUTION;INTRAVENOUS 213994-001 Oct 16, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Sagent Pharms Inc EPHEDRINE SULFATE ephedrine sulfate SOLUTION;INTRAVENOUS 214528-001 Mar 9, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Nexus EMERPHED ephedrine sulfate SOLUTION;INTRAVENOUS 213407-001 Apr 17, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for EPHEDRINE SULFATE

Country Patent Number Title Estimated Expiration
Japan 2023091072 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法 (COMPOSITIONS COMPRISING EPHEDRINE OR EPHEDRINE SALT AND METHODS OF MAKING AND USING THOSE COMPOSITIONS) ⤷  Sign Up
Mexico 2021013888 COMPOSICIONES QUE COMPRENDEN EFEDRINA O UNA SAL DE EFEDRINA Y METODOS DE FABRICACION Y USO DE LAS MISMAS. (COMPOSITIONS COMPRISING EPHEDRINE OR AN EPHEDRINE SALT AND METHODS OF MAKING AND USING SAME.) ⤷  Sign Up
Japan 2022532657 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法 ⤷  Sign Up
Australia 2020276619 Compositions comprising ephedrine or an ephedrine salt and methods of making and using same ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for EPHEDRINE SULFATE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1110543 SPC/GB08/005 United Kingdom ⤷  Sign Up SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022.
1110543 08C0004 France ⤷  Sign Up PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.